TABLE 1.
Patient characteristics and interview statistics.
| Variable | N(%) or M(SD) | |
|---|---|---|
| DFCI participants (N = 14) |
SCC participants (N = 14) |
|
| Female | 8 (57%) | 7 (50%) |
| Age | 54.3 (9.7) years | 51.6 (12.4) years |
| Race | ||
| White | 14 (100%) | 12 (86%) |
| American Indian/Alaska Native | 1 (7%) | |
| Black/African American | 1 (7%) | |
| Current/historical opioid use | ||
| Short-acting | 13 (93%) | 14 (100%) |
| Long-acting | 8 (57%) | 8 (57%) |
| Cancer type | ||
| Head and neck | 3 (21%) | 2 (14%) |
| Breast | 2 (14%) | 1 (7%) |
| Colorectal | 3 (21%) | 2 (14%) |
| Lung | 3 (21%) | 1 (7%) |
| Hemopoietic | 2 (14%) | |
| Kidney | 2 (14%) | 1 (7%) |
| Prostate | 1 (7%) | |
| Neuroendocrine | 1 (7%) | |
| Pancreatic | 1 (7%) | |
| Cervical | 1 (7%) | |
| Ovarian | 1 (7%) | |
| Polycythemia Vera | 1 (7%) | |
| Other(Desmoid fibromatosis) | 1 (7%) | 1 (7%) |
| Interview length(minutes) | ||
| M(SD) | 51.86 (16.06) | 42.57 (12.11) |
| Range | 24–78 | 22–64 |
| Zoom interviews | 14 (100%) | 12 (86%) |
| Rural residence | 0 | 3 (21%) |